Absorption and disposition of bromate in F344 rats

Toxicology

Volumn 300, Issue 1-2, 2012, Pages 83-91

  Bull, Richard J ^a   Kolisetty, Narendrababu ^b   Zhang, Xiaoling ^b   Muralidhara, Srinivasa ^b   Quiñones, Oscar ^c   Lim, Kok Yong ^d   Guo, Zhongxian ^d   Cotruvo, Joseph A ^e   Fisher, Jeffrey W ^f   Yang, Xiaoxia ^f   Delker, Don ^g   Snyder, Shane A ^c   Cummings, Brian S ^b  

^a MoBull Consulting   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c SOUTHERN NEVADA WATER AUTHORITY   (United States)

^d Water Quality Office Public Utilities Board   (Singapore)

^e Joseph Cotruvo and Associates LLC   (United States)

^f NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^g UNIVERSITY OF UTAH   (United States)

Author keywords

Absorption; Bromate; Disposition; Rat; Reaction products

Indexed keywords

BROMATE; CARCINOGEN; CREATININE; DRINKING WATER;

ABSORPTION; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD SAMPLING; BROMINATION; DEGRADATION; DISEASE PREDISPOSITION; FEMALE; HALF LIFE TIME; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; REACTION TIME; REDUCTION KINETICS; URINARY EXCRETION;

ABSORPTION; ADMINISTRATION, ORAL; ANIMALS; BROMATES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALF-LIFE; RATS; RATS, INBRED F344;

RATTUS;

EID: 84863813101     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.06.002     Document Type: Article

References (35)

1. Arai T., Kelly V.P., Minowa O., Noda T., Nishimura S. The study using wild-type Ogg1 knockout mice exposed to potassium bromate shows no tumor induction despite an extensive accumulation of 8-hydroxyguanine in kidney DNA. Toxicology 2006, 221:179-186.
2. Ballmaier D., Epe B. Oxidative damage induced by potassium bromate under cell-free conditions and in mammalian cells. Carcinogenesis 1995, 16(2):335-342.
3. Bonacquisti T.P. A drinking water utility's perspective on bromide, bromate, and ozonation. Toxicology 2006, 221:145-148.
4. Carr A.C., Decker D.A., Park Y., Frei B. Comparison of low-density lipoprotein modification by myeloperoxidase-derived hypochlorous and hypobromous acid. Free Rad. Biol. Med. 2001, 31(1):62-72.
5. Cotruvo J.A., Keith J.D., Bull R.J., Pacey G.E., Gordon G. Bromate reduction in simulated gastric juice. J. AWWA 2010, 102(11):77-86.
6. Cotruvo J.A., Bull R.J., Cummings B.S., Delker D., Guo Z., Fisher J., Quinones O., Snyder S.A., Ong C.N. Low Dose Risks from Bromate: The Relationship between Drinking Water Concentrations and Actual Dose to Susceptible Organs in Rats and Humans. Final Project Report WRF-4042 2012, Water Research Foundation, Denver, CO.
7. DeAngelo A.B., George M.H., Kilburn S.R., Moore T.M., Wolf D.C. Carcinogenicity of potassium bromate administered in the drinking water to male B6C3F1 mice and F344/N rats. Toxicol. Pathol. 1998, 26(5):587-594.
8. Delker D., Hatch G., Allen J., Crissman B., George M., Geter D., Kilburn S., Moore T., Nelson G., Roop B., Slade R., Swank A., Ward W., DeAngelo A. Molecular biomarkers of oxidative stress associated with bromate carcinogenicity. Toxicology 2006, 221:158-165.
9. Fisher J., Bull R.J. Development of a rat dosimetry model for bromate. Toxicology 2006, 221(2-3):235-240.
10. Fujii M., Oikawa K., Saito H., et al. Metabolism of potassium bromate in rats. I. In vivo studies. Chemosphere 1984, 13:1207-1212.
11. Gold, L.S., Slone, T.H., Manley, M.B., Garfinkel, G.B., Ames, B.N., 2012. Carcinogen Potency Database (CPDB) (online). Available: February 2, 2012. http://potency.berkeley.edu/pub/tables/chemicalsummary.
12. Guo Z.X., Cai Q.T., Yu C.H., Yang Z.G. Determination of bromate and bromoacetic acids in water by ion chromatography-inductively coupled plasma mass spectrometry. J. Anal. At. Spectrom. 2003, 18:1396-1399.
13. Hawkins C.L., Davies M.J. The role of reactive N-bromo species and radical intermediates in hypobromous acid-induced protein oxidation. Free Rad. Biol. Med. 2005, 39:900-912.
14. Himmelfarb J., McMonagle E., McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int. 2000, 58:2571-2578.
15. Hua G.H., Reckhow D.A. Determination of TOCl, TOBr and TOI in drinking water by pyrolysis and off-line ion chromatography. Anal. Bioanal. Chem. 2006, 384:495-504.
16. IARC IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 73: Some Chemicals that Cause Tumors of the Kidney or Urinary Bladder and Some other Substances 1999, 73:481-496. WHO, International Agency for Research on Cancer.
17. ISO, 2004. International Standard Organisation, ISO/FDIS 9562:2004(E). Water quality - determination of adsorbable organically bound halogens (AOX).
18. Jones D.P., Mody V.C., Carlson J.L., Lynn M.J., Sternberg P. Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Rad. Biol. Med. 2002, 33(9):1290-1300.
19. Keith J.D., Pacey G.E., Cotruvo J.A., Gordon G. Experimental results from the reaction of bromate ion with synthetic and real gastric juices. Toxicology 2006, 221:225-228.
20. Kurokawa Y., Aoki S., Matsushima Y., Takamura N., Imazawa T., Hayashi Y. Dose-response studies on the carcinogenicity of potassium bromate in F344 rats after long-term oral administration. J. Natl. Cancer Inst. 1986, 77(4):977-982.
21. Murata M., Bansho Y., Inoue S., Ito K., Ohnishi S., Midorikawa K., Kawanishi S. Requirement of glutathione and cysteine in guanine-specific oxidation of DNA by carcinogenic potassium bromate. Chem. Res. Toxicol. 2001, 14:678-685.
22. Parsons J.L., Chipman J.K. The role of glutathione in DNA damage by potassium bromate in vitro. Carcinogenesis 2000, 15(4):311-316.
23. Pastore A.R., Massoud C., Motti A.L., Russo G., Fucci C., Cortese G., Federici Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine, and 2-mercaptopropionylglycine in plasma and urine. Clin. Chem. 1998, 44(4):825-832.
24. Pattison D.L., Davies M.J. Kinetic analysis of the reactions of hypobromous acid with protein components: implications for cellular damage and use of 3-bromotyrosine as a marker of oxidative stress. Biochemistry 2004, 43:4799-4809.
25. Rao G.N., Edmondson J., Elwell M.R. Influence of dietary protein concentration on severity of nephropathy in Fischer 344 (F-344/N) rats. Toxicol. Pathol. 1993, 21(4):353-361.
26. Snyder S.A., Vanderford B.J., Rexing D.J. Trace analysis of bromate, chlorate, iodate, and perchlorate in natural and bottled waters. Environ. Sci. Technol. 2005, 39:4586-4593.
27. Speit G., Haupter S., Schütz P., Kreis P. Comparative evaluation of the genotoxic properties of potassium bromate and potassium superoxide in V79 Chinese hamster cells. Mutat. Res. 1999, 439:213-221.
28. Tanaka K., Oikawa K., Fukuhara C., Saito H., Onosaka S., Min K.-S., Fujii M. Metabolism of potassium bromate in rats. II. In vitro studies. Chemosphere 1984, 13(11):1213-1219.
29. Umemura T., Kitamura Y., Kanki K., Maruama S., Okazaki K., Imazawa T., Nishimura T., Hasegawa R., Nishikawa A., Hirose M. Dose-related changes of oxidative stress and cell proliferation in kidneys of male and female F344 rats exposed to potassium bromate. Cancer Sci. 2004, 95(5):393-398.
30. Umemura T., Kanki K., Kuroiwa Y., Ishii Y., Okano K., Nohmi T., Nishikawa A., Hirose M. In vivo mutagenicity and initiation following oxidative DNA lesion in the kidneys of rats given potassium bromate. Cancer Sci. 2006, 97(9):829-835.
31. Umemura T., Tasaki M., Kijima A., Okamura T., Inoue T., Ishii Y., Suzuki Y., Masui N., Nohmi T., Nishikawa A. Possible participation of oxidative stress in causation of cell proliferation and in vivo mutagenicity in kidneys of gpt delta rats treated with potassium bromate. Toxicology 2009, 257(1-2):46-52.
32. US EPA, 1997. USEPA Method 1650 Adsorbable Organic Halides by Adsorption and Coulometric Titration, Reversion C.
33. US EPA, 2003. National Primary Drinking Water Regulations: Stage 2 Disinfectants and Disinfection Byproducts Rule. Federal Register, CFR Parts 141, 142, 143, August 18, 2003.
34. Wolf D.C., Crosby L.M., George M.H., Kilburn S.R., Moore T.M., Miller R.T., DeAngelo A.B. Time- and dose-dependent development of potassium bromate-induced tumors in male Fischer 344 rats. Toxicol. Pathol. 1998, 26:724-729.
35. Zhang Z., De Silva D., Sun B., Fisher J., Bull R.J., Cotruvo J.A., Cummings B.S. Cellular and molecular mechanisms of bromate-induced cytotoxicity in human and rat kidney cells. Toxicology 2010, 269:13-23.